India is fast developing as one of the hottest destinations for clinical trials, even for medicines that has got demand anywhere in the world. It is devious to test drugs for diseases like cancer (it is understandable to test India-specific drugs like anti-malaria or anti-diarrhea) as it is as common in the West as it is here. But it is going on regardless because conducting clinical trials in India will be 80 per cent cheaper than in the West. Equally appalling is the fact that these companies themselves appoint the investigator and the Drugs and Cosmetics Act allows them to have the final say! Th at means there is no counterbalance to the obvious underreporting by the company appointed investigators in case of deaths and health hazards.
No comments:
Post a Comment